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Absolute pitch, the ability to identify or produce the pitch of a sound without a reference
point, has a critical period, i.e., it can only be acquired early in life. However, research
has shown that histone-deacetylase inhibitors (HDAC inhibitors) enable adult mice to
establish perceptual preferences that are otherwise impossible to acquire after youth. In
humans, we found that adult men who took valproate (VPA) (a HDAC inhibitor) learned to
identify pitch significantly better than those taking placebo—evidence that VPA facilitated
critical-period learning in the adult human brain. Importantly, this result was not due to
a general change in cognitive function, but rather a specific effect on a sensory task
associated with a critical-period.
Keywords: critical period reopening, learning, absolute pitch, valproate, histone-deacetylase inhibitors, human
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INTRODUCTION
Absolute pitch (AP), the ability to identify or produce the pitch
of a musical sound without any reference point, has long fas-
cinated musicians, music scholars, psychologists, and neurosci-
entists (Stumpf, 1883; Mull, 1925; Takeuchi and Hulse, 1993;
Zatorre, 2003; Levitin and Rogers, 2005). Individuals who possess
AP, constituting about 0.01% of the general population, are able
to identify the pitch class, i.e., one of the 12 notes of the Western
musical system, e.g., C, D, G#, of a sound with great accuracy
(varying between 70–99%, depending on the task, as compared
to 10–40% for non-AP individuals, Takeuchi and Hulse, 1993).
Their errors are usually not more than a semitone away from the
target sound, as compared to 3 or more semitones for non-AP
individuals. AP possessors also make octave errors, i.e., they iden-
tify the pitch class, but not the pitch height correctly, labeling a C4
(middle C) as C5, an octave higher. Pitch class and pitch height
identification are thus believed to be separate processes, and only
the former constitutes a crucial test for AP (Takeuchi and Hulse,
1993; Levitin and Rogers, 2005), which AP possessors perform
effortlessly and automatically. Their reaction times are faster, at
least when responding correctly, than those of non-possessors
(Miyazaki, 1990), suggesting that the former have direct access
to pitch names in memory, whereas the latter might rely on rela-
tive pitch to calculate pitch class. In light of AP possessors’ highly
accurate and automatic identification of pitch class, it has been
suggested that in addition to perceptual mechanisms, AP involves
the association of (verbal) labels for pitch classes in long-term
memory (Zatorre, 2003; Levitin and Rogers, 2005).
The central role of these associations is further supported by
functional imaging studies showing the involvement of the left
posterior dorsolateral frontal cortex and the planum temporale,
known to be responsible for learning conditional associations
(Zatorre et al., 1998; Ohnishi et al., 2001; Bermudez and Zatorre,
2005; Wilson et al., 2009). In addition, AP possessors have a
larger planum temporale (Zatorre et al., 1998), with a left-right
asymmetry involving a smaller right planum temporale and an
increased leftward asymmetry in AP possessors (Keenan et al.,
2001), and show hyperconnectivity in the temporal cortex (Loui
et al., 2011), facilitating tone-label mapping.
Importantly, acquiring AP has a critical period (Levitin and
Zatorre, 2003; Russo et al., 2003). A critical period is a fixed
window of time, usually early in an organism’s lifespan, during
which experience has lasting effects on the development of brain
function and behavior. The principles of critical period phenom-
ena and neural plasticity are increasingly well understood both
at the behavioral/experiential (Kleim and Jones, 2008) and at the
molecular/cellular level (Hensch, 2005). Specifically, behaviorally
induced plasticity in the healthy brain, typically after the end
of the relevant critical period, can lead to improvement beyond
normal or average performance levels. However, for many tasks,
this requires targeted training—simple routine use is often insuf-
ficient. The factors known to influence the efficiency of such
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targeted training include the number of repetitions involved, the
intensity of the training as well as the relevance or saliency of
the stimuli or task trained. Importantly, such training-induced
learning is quite specific to the trained task and to the under-
lying brain networks, although some transfer to other, related
domains of knowledge or skills is sometimes possible. At the cel-
lular level, critical periods close when maturational processes and
experiential events converge to cause neuoro-physiological and
molecular changes that dampen or eliminate the potential for fur-
ther change (Hensch, 2005; Bavelier et al., 2010), thus imposing
“brakes” on neuroplasticity. One of the epigenetic changes lead-
ing to decreased plasticity after the critical period involves the
action of HDAC, an enzyme that acts as an epigenetic “brake” on
critical-period learning (Morishita and Hensch, 2008; Qing et al.,
2008). Research has shown that inhibition of HDAC can reopen
critical-period neuroplasticity in adult mice to enable recovery
from amblyopia (Putignano et al., 2007; Silingardi et al., 2010),
and to facilitate new forms of auditory learning (Yang et al., 2012).
The age of onset of musical training has been shown to pre-
dict AP acquisition (Deutsch et al., 2009), indicating the presence
of a critical period. AP is most typically seen in individuals who
startedmusical training before 6 years of age (Levitin and Zatorre,
2003; Russo et al., 2003; Miyazaki and Ogawa, 2006). Indeed, the
distribution of the age of first formal musical training in a large
number of individuals with AP can be modeled with a gamma
function with a mode at 4–6 years (Levitin and Zatorre, 2003).
Training that begins after the age of 9 very rarely leads to AP,
and there are no known cases of an adult successfully acquiring it
(Brady, 1970; Ward and Burns, 1999; Levitin and Rogers, 2005).
The appropriate type of input, i.e., training associating absolute
pitches to labels, thus needs to be available before the end of the
critical period for AP to develop. For most individuals, this is not
the case, as the two major sources of auditory input during early
development, language, and theWesternmusical traditionmainly
rely on relative pitch, explaining why not all musically trained
individuals have AP. In the absence of AP cues during the criti-
cal period, the perceptual system is reorganized, shifting weight
from absolute to relative pitch information (Takeuchi and Hulse,
1993; Saffran and Griepentrog, 2001; Saffran, 2003, although see
Trehub, 2003 for a somewhat different view).
AP is thus particularly interesting from a neuro-scientific per-
spective, as it provides a model for understanding the interaction
of genes and experience on the development of neural and cogni-
tive function (Zatorre, 2003). In the current study, we explored
whether a reopening of the critical period was possible for AP
learning in human adults. We sought to establish whether the
administration of valproate (VPA), a commonly used anticonvul-
sant and mood stabilizer, known to inhibit HDAC and modulate
the epigenome to promote neuroplasticity (Phiel et al., 2001;
Schloesser et al., 2007; Machado-Vieira et al., 2011) would facil-
itate training naïve, non-musician adults on the identification of
pitch classes in a classical AP task (Deutsch et al., 2006).
Previous studies (Meyer, 1899; Mull, 1925; Wedell, 1934;
Hartman, 1954; Lundin, 1963; Cuddy, 1968; Russo et al.,
2003) have shown that training improves adults’ AP abilities
only under restricted conditions. Three factors appear to play
a particularly important role: participant’s previous musical
training/experience, whether a single tone or a series of tones
are used for training, and the duration/intensity of the training.
Notable improvement is achieved only when musically highly
proficient participants are trained on a single note for exten-
sive periods (from several weeks to several months) and tested
on the recognition of this single target tone among several non-
target ones (Mull, 1925; Cuddy, 1968). It is possible, however, that
at least in some such cases, the improvement is actually due to
greater familiarity with the particular task, tone series or proce-
dure, rather than to a genuine increase in AP ability (Takeuchi and
Hulse, 1993). Improvement is muchmore limited whenmusically
untrained participants are tested (Cuddy, 1968), when partici-
pants are trained on a series of pitch classes rather than on just
one pitch class (Cuddy, 1968), or when training is relatively short
or less intense (Vianello and Evans, 1968). Prior musical training
is particularly important, as musically proficient participants typ-
ically perform better than chance (Mull, 1925; Lundin, 1963) and
better than musically naïve participants (Cuddy, 1968) on pitch
identification already prior to AP training, it is thus not surprising
that some AP improvement may be achieved in this population.
A recent finding further shows that in addition to early musi-
cal training, the current musical environment also contributes
to (the maintenance of) AP abilities, suggesting the presence of
some residual plasticity for AP, at least in individuals in whom AP
emerged during the early critical period (Wilson et al., 2012).
The use of a single tone vs. a series of tones for training is also
highly relevant, as the two training methods might tap into differ-
ent underlying pitch perception abilities or might represent tasks
of varying degrees of complexity. In our current understanding,
the identification of only one pitch class serving as an internal
reference, sometimes referred to as quasi-AP or single tone AP, is
qualitatively different from true AP, whereby the individual is able
to identify a large number of pitch classes automatically and with-
out an internal or external reference. Albeit often similar in the
percentage of correct identifications, the two types of abilities can
be distinguished on the basis of reaction times, as AP possessors
have faster reaction times than absolute tuning tone processors
(Miyazaki, 1990; Levitin and Rogers, 2005). It needs to be noted,
however, that according to some authors (e.g., Cuddy, 1968) the
single tone method might also lead to true AP eventually.
The length and intensity of training also affects performance
(Brady, 1970). Fast improvement is observed for tones that are
separated by large pitch distances, whereas more extended train-
ing is necessary for pitches that are closer together (Hartman,
1954). Not surprisingly, the latter are in general harder to learn
and to discriminate than the former, with musically naïve partici-
pants not being able to achieve discrimination errors smaller than
about 5 semitones with pitch classes that are separated by small
distances (Wedell, 1934). Further, interference effects are some-
times observed when tone series are taught gradually, involving
the introduction of new tones that fall in between already trained
ones, decreasing pitch distance, and disrupting the subjective
organization of the scale.
To assess whether taking VPA could reopen the opportunity
for critical-period-like learning in adults, we conducted a ran-
domized, double-blind, placebo-controlled study, in which 24
young adult males received either placebo or VPA treatment in
a cross-over design with two treatment arms. Participants under-
went 15 days of treatment during which they took capsules (VPA
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or placebo) each day. During the second week of treatment,
participants observed training videos that taught participants
to associate six pitch classes from the 12-tone Western musical
system (e.g., C, D, E, F#/Gb, G#/Ab, A#/Bb) with six proper names
(e.g., Sarah, David, Francine, Jimmy, Karen, Leo).We chose to use
proper names instead of the actual note names to make the task
equally novel and accessible for participants with and without any
priormusical training, and to divert attention from themusic the-
oretical aspect of the task. We acknowledge that this may interfere
with existing knowledge of actual musical note names in the par-
ticipants who had sufficient musical training, but given that there
were few such participants in our study, we considered that the
advantages of using proper names outweighed the potential neg-
ative influence of such interference. On day 15, participants were
given a post-treatment assessment for AP in which they heard 18
synthesized piano tones and had to identify the proper name asso-
ciated with the pitch class of each tone. After the first treatment
arm, a washout period of 2 to 4 weeks elapsed. Eighteen out of the
24 original participants then entered the second treatment arm,
which was similar to the first one, except that the drug (VPA or
placebo) not received during the first arm was administered.
Given the difficulty of improving AP performance in adult-
hood, we hypothesize that in our task, even a small advantage in
pitch class identification in the VPA as compared to the placebo
group is suggestive of the reopening of plasticity, as musically
naïve participants were trained for a relatively short time period
on several pitch classes, conditions under which no existing study
has shown any improvement in AP. The strong hypothesis is
that there might be improvement in the VPA condition in both
arms of the design. However, since new training is introduced
in the second treatment arm, successful learning in the first arm
might carry over to and interfere with learning in the second
arm. Effects are thus more likely in the first arm only. This study
is, therefore, intended as a proof-of-concept demonstration that
critical-period-like AP learning may be at least partly restored by
using a drug to remove the epigenetic brakes on neural plasticity.
MATERIALS AND METHODS
PARTICIPANTS
The twenty four participants who took part in the study
were healthy, right-handed, monolingual, English-speaking adult
males (median age= 23, range= 18–27). A software malfunction
corrupted the data for one participant in the first treatment arm,
leaving 11 who took VPA, and 12 who took placebo. Participants
gave informed, written consent following the protocol approved
by the University of British Columbia clinical ethics review board
and Health Canada. Exclusion criteria for the study included tak-
ing any medication with psychoactive effects, recreational drug
use in the 6 months prior to participation, drug or alcohol abuse,
being functionally bilingual or studying a second language at the
university level, having perfect pitch or AP for musical tones, and
being involved in an occupation requiring a high level of vigilance.
Only males were included in the study as a caution for potential
health risks that VPA might have on pregnant women.
Participants did not report having complete, partial or quasi
AP, and have received no or little musical training (mean 2.4
years). Importantly, those who had received any musical training
all started after the age of 7 years, some as late as 17 years (with
a mean and a median of 12 years), well beyond the critical age of
4–6 years (Levitin and Zatorre, 2003). It is, therefore, unlikely that
there were AP possessors among our participants.
During a screening session, we confirmed each participant’s
suitable health by means of a medical examination with a physi-
cian, which included a medical history. We also collected a blood
sample to check for normal levels of hepatic enzymes, platelets,
amylase, and ammonia. These as well as participants’ psycholog-
ical state and mood were also monitored throughout the entire
duration of the study to screen for potential adverse effects.
The participants completed questionnaires at the screening ses-
sion about demographics, music experience, language training,
and handedness, as well as an assessment of IQ with the North
American Adult Reading Test (NAART). Table 1 summarizes
these data.
We asked participants to maintain normal patterns of con-
sumption of caffeinated beverages over the course of the study.
At the end of their participation, we remunerated the participants
for the time they devoted to the study at a rate of $10 per hour.
The maximum remuneration for participants who completed the
study came to $270.
Of the twenty four participants, 18 completed the second
treatment arm. The six participants who only completed the
first treatment arm either had to leave the study or had to be
removed partway through for the following reasons: scheduling
conflicts; travel; concern that side effects during the second treat-
ment session might interfere with performance at a job interview;
suffering a concussion due to an unrelated accident during the
second treatment arm; loss of contact during the washout period
with no explanation. No participant reported leaving the study
because of any actual side effects from the treatment.
MATERIAL
TRAINING
The training video taught participants to associate six pitch
classes from the 12-tone Western musical system (e.g., C, D, E,
F#/Gb, G#/Ab, A#/Bb) with six proper names (e.g., Sarah, David,
Francine, Jimmy, Karen, Leo). Each pitch class was presented in
three consecutive octaves using synthesized piano tones. During
Table 1 | Participants’ data from the screening assessment.
Mean (SD) Range Median
Age (years) 22.6 (2.6) 18–27 23
IQ (FSIQ) 110 (6.8) 97–122 110
Handedness* 86.3 (16.1) 37–100 89
Time spent learning a second
language (years)
2 (2.1) 0–8 2
Proficiency on a second language** 1.1 (0.86) 0–3 1
Number of years of music practice 2.4 (3) 0–10 1
Age the music training began
(years)***
12 (2.5) 7–17 12
*The Edinburgh Handedness Inventory scale ranges from −100 (fully left-
handed) to +100 (fully right-handed). **Proficiency on a second language was
based on a self-rating scale from 0 to 5, with 5 being very proficient. ***These
statistics are based upon the 14 participants who had at least some musical
practice experience.
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the training, a name would appear on the screen while the subject
heard examples of the corresponding pitch class. The training for
the second treatment arm involved six pitch classes and six proper
names that were not used in the first arm of the study. Thus, for
the two treatment arms in total, we used all 12 pitch classes of the
Western musical system, and presented them in three consecutive
octaves, based on Deutsch et al.’s study (2006).
The training videos included three blocks. Each block provided
an opportunity for the participants to associate the six names with
the corresponding pitch classes. During the first block, a subject
saw one of the six names on the screen, and heard in succession
the three examples of the pitch class corresponding to that name.
The examples, which were piano tones of the same pitch class in
three consecutive octaves, occurred one after another from the
lowest octave to the highest. The second block was identical to
the first, except that the ordering for the octaves was scrambled,
such that the piano tones corresponding to a name did not neces-
sarily occur from lowest to highest. In the third block, the stimuli
occurred in a semi-random order, one at a time, and paired with
the corresponding name. The semi-randomization was unique,
and followed the same rules as in the task (see below). The length
of the training was based on the duration of the VPA regimen
employed in previous studies using VPA with healthy participants
(Bell et al., 2005a,b). Specifically, participants trained for 7 days
(from the 8th to the 14th day of the 14-day-long regimen), i.e.,
starting once the full dose of VPA was reached.
TEST
During test, the six proper names appeared in a horizontal row
on the screen in the same order for every subject (Figure 1A).
Participants heard one synthesized piano tone per trial, for a total
of 18 trials, in a semi-randomized order, the only constraint being
that successive tones were separated by an interval greater than
one octave. The tones were 500ms in duration and interleaved by
3750ms of silence, and were identical to the stimuli used during
training. During the 3750ms period following each tone, partici-
pants had to identify the proper name associated with the pitch
class of the tone by pressing the keyboard key corresponding
to the first letter of the associated name (Figure 1A). The max-
imum score for the task was 18, the minimum 0, and chance
performance corresponded to a score of 3.
Our stimuli were synthesized piano tones as in Deutsch et al.’s
(2006) study. Unlike pure tones, stimuli generated by (synthe-
sized) musical instruments contain cues other than frequency to
pitch class identity, e.g., timbre. Intermediate and poor AP pos-
sessors are known to perform considerably worse with pure tones
than with instrument-generated sounds (Lockhead and Byrd,
1981; Bermudez and Zatorre, 2009). Since we only expected a
moderate improvement in AP perception in our study, we decided
to avoid using pure tones.
This procedure was similar to that used by Deutsch and col-
leagues (Deutsch et al., 2006). However, it differed in two primary
ways: (1) We divided the total set of test tones (36 in total) in
half. Doing this enabled us to use an equal number of notes in the
two task versions for participants who completed both treatment
arms. As a result, we had half as many trials (18 in total) as
Deutsch and colleagues. (2) Our participants learned associations
FIGURE 1 | (A) The setup of the AP task. The purple characters and
squares indicate names and corresponding keys used in one treatment
arm, the blue ones indicate those used in the other treatment arm. Colors
appear here for illustration purposes only. Only black characters were used
in the actual experiment and response keys were not highlighted. (B) The
cross-over design of the study with the two treatment arms, VPA regimen,
training and test times.
between common names and the test tones, whereas Deutsch and
colleagues used musical note names.
The names were common first names, the first letters of which
appeared on the same row of the keyboard (e.g., s, d, f, j, k, l).
Half of the names were female, and the other half male. For one
treatment arm, the names were Sarah, David, Francine, Jimmy,
Karen, and Leo. For the other, Eric, Rachel, Tyler, Irene, Owen,
and Peggy. All of the names were bisyllabic and started with a dif-
ferent letter than the actual name of the musical note with which
they were associated. The pitch classes in each treatment arm
formed a whole-tone scale by selecting every other pitch from the
12-tone keyboard. For one treatment arm, the pitch classes were
thus A#/Bb, C, D, E, F#/Gb, G#/Ab, for the other A, B, C#/Db,
D#/Eb, F, G.
At the beginning of the task, there were four practice trials
allowing participants to get used to the name—response key asso-
ciations. During each practice trial, participants heard one of the
common names spoken over the headphones, and then had to
press the first letter of the name on the keyboard. We synthesized
the names using an American English female voice in MBROLA
(Dutoit, 1997). Participants only heard these synthesized names
during the practice trials.
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The AP task was administered in the post-treatment assess-
ment only, because the participants had to learn novel associa-
tions between the proper names and the musical notes during
training.
PROCEDURE
We used a randomized, double-blind, placebo-controlled design
with a crossover between the two treatment arms (Figure 1B).
We randomly counterbalanced participants into two treatment
groups (VPA and placebo) in counterbalanced blocks of four.
We used random allocation software to produce the randomiza-
tion (Saghaei, 2004). The participants, experimenters, and raters
were blind to treatment conditions. The eighteen participants
who completed a second treatment arm crossed over into the
treatment condition they had not undergone during their first
treatment regimen. That is, a subject who received placebo first
took VPA for the second treatment arm, and vice versa.
Each treatment arm comprised two assessments, one pre-
treatment, and one post-treatment, separated by a two-week
treatment period. The pre-treatment assessment consisted of
blood samples and tests of mood and cognitive abilities 1. No
AP assessment could be administered at this point, as partici-
pants, not having considerable musical training, did not neces-
sarily know the names of musical notes. On day 15, participants
returned for a post-treatment session that was equivalent to the
pre-treatment session, with the addition of a test for AP. There
was a washout period of at least 2 weeks and nomore than 4 weeks
between the first and second treatment arms. The participants
began taking capsules on the morning after the pre-treatment
assessment. For participants in the VPA condition, the regimen
included taking 500mg (two 250mg capsules, one in the morn-
ing and one at night) for 3 days (days 1–3), followed by 1000mg
(four 250mg capsules, one in the morning, one in the afternoon,
and two at night) for 11 days (days 4–14), and taking 250mg
(one capsule) on the morning of the post-treatment assessment
(day 15).
The design of the treatment regimen was based upon previous
studies (Bell et al., 2005a,b), and complied with Health Canada
guidelines for administering VPA. The placebo regimen was iden-
tical to the VPA regimen and the placebo capsules were matched
with the VPA capsules in terms of weight and appearance.
On days 8–14 of each treatment, we instructed participants to
undergo an on-line training program for approximately 10min
per day. During each online training session, they observed a
video, which trained associations between piano tones and proper
names. After each video, the website prompted participants to
answer a question about the content of the training video in order
to gauge quality of attention (e.g., “How many women played
notes in the video?,” “How many notes did each person play?”
etc.). The website also recorded information about the start time
and duration of the training.
Participants who completed both treatment arms filled out a
form in which we asked them to guess during which treatment
1Along with the adult test of AP reported here, participants were also tested
on pilot versions of infant perceptual tasks, which we are developing for use
with adults.
arm we had administered the VPA, and to report any symptoms
they experienced while taking the capsules. Every laboratory ses-
sion included a blood sample collection and assessments of mood
and cognitive ability. We assessed mood using the Visual Analog
Scales (VAS) for mood, the Beck Depression Inventory (BDI-II),
and the Altman Self-Rating Scale for Mania (ASRM).
The cognitive assessment included the Ruff Neurobehavioral
Inventory (RNBI-24), Rey Auditory Verbal Learning Test
(RAVLT), Stroop Task, and Digit Span Test. We also assessed
depth perception with the RANDOT Pre-school Stereoacuity
Test, and visual acuity with the Regan Acuity Test. We used dif-
ferent word lists of the RAVLT for the first and second treatment
arms. In addition to using them as experimental variables, we also
monitored the results of the BDI-II and the RNBI-24 to iden-
tify any adverse effects of taking VPA on mood and cognition
(e.g., suicidal thoughts or confusion). We did not find any adverse
effects in any of the participants.
To assess AP, we used a computerized task programmed in
PsyScope X Build 55 (http://psy.ck.sissa.it/). Participants worked
alone in a room, and followed instructions on the computer
screen about how to respond during the task by pressing keys
on the computer keyboard. An experimenter introduced the task,
and returned to the testing room after the completion of the task
to record any comments. We used different stimulus sets for the
two treatment arms in order to minimize learning and carry-over
effects.
RESULTS
FIRST TREATMENT ARM
In the first treatment arm, the average correct responses were
5.09 in the VPA group and 3.50 in the placebo group (Figure 2).
Participants2 in the VPA condition performed significantly above
chance, which was 18/6 = 3 [t(10) = 4.08, p = 0.002], whereas
those in the placebo condition performed at chance level [t(11) =
1.32, p = 0.21]. To further probe performance, we plotted the
data with errors shown as deviations from the correct pitch cate-
gory measured in whole tones (Figure 3). The distribution of the
placebo group is flatter than that of the VPA group, indicating
greater randomness. In addition, errors appear to have been ran-
dom in the VPA condition, though participants were correct more
often. This suggests that learning was absolute in the sense that the
structure of the categories participants formed did not represent
nearness from one category to another, strengthening the finding.
In a One-Way ANOVA with Condition (VPA/placebo) as
a between-subject factor, we obtained a significant effect of
Condition [F(1, 21) = 6.37, p = 0.02] due to better performance
in the VPA group compared to the placebo group.
To test whether this positive effect of VPA was specific to
AP perception, or whether it resulted from a general change in
mood and/or cognition, we conducted ANOVAs with Time (pre-
treatment/post-treatment) as a within-subject and Treatment
(VPA/placebo) as a between-subject factor on the measures of
mood and/or cognition (with the exception of the RANDOT
Stereoacuity test, which yields ordinal data and was thus entered
2A software malfunction corrupted the data for one participant in the first
treatment arm, leaving 11 who took VPA and 12 who took placebo.
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FIGURE 2 | Average number of correct responses in the AP task in the
first (left) and second (right) treatment arm. Errors bars indicate the
standard error of the mean. The dashed red line indicates chance
performance.
FIGURE 3 | The AP data in the first treatment arm, with errors shown
as deviations from the correct pitch category measured in whole
tones. Pitch categories repeat every octave. Thus, +3 whole tones is the
same as −3 whole tones, and the corresponding bars in the figure
represent the same responses. The expected correct response is a
distribution with a mode at 0, with a deviation of 0.
into the non-parametric Friedman test). A significant Time X
Treatment interaction would indicate a possible differential effect
of VPA compared to placebo. No such interaction was obtained
for any of the measures. Table 2 summarizes the scores of the
measures for which a significant main effect was obtained.
For the participants in the VPA condition, the average blood
concentration of VPA at the post-treatment assessment was
567µmol/L (range: 261–854, SD = 165.53). The active range
of VPA is considered 350–700µmol/L. The concentration for
one subject fell below this range (261µmol/L), and the concen-
trations for three other participants fell above this range (708,
732, 854µmol/L). The concentrations for the remaining eight
participants fell within the typical active range. Participants’ per-
formance on the AP task did not show a significant correlation
with VPA levels in the blood (r = .36, n = 11, p = 0.28).
We also calculated the number of training sessions each subject
completed. We counted a training session as complete if the sub-
ject both watched the full length of the video (up to within 15 s
of the end) and answered the subsequent test question correctly.
Based on these criteria, participants completed an average of 4.63
AP training sessions (SD = 2.06, range: 0–7). Notably, 0 training
sessions did not signify that a subject did no training; all partici-
pants did train for this task online. Participants who completed 0
training sessions either systematically stopped the video partway
through, or watched the entire length and then failed to answer
the question at the end correctly. There was no significant cor-
relation between the number of completed training sessions and
performance (r = 0.13, n = 23, p = 0.55).
We also ran a correlation analysis to compare AP performance
in this treatment arm with the number of years of musical train-
ing each subject had completed (r = −0.12, n = 23, p = 0.60),
and the age of start of musical training for those participants
who did havemusical training (r = −0.20, n = 14, p = 0.50), but
neither reached significance. Importantly, our participants were
musically naïve, had little musical training, and all started music
after age 7 with a mean age of 12, i.e., after the critical period.
Thus, the absence of any correlation between AP performance in
our study and participants’ musical training is not unexpected.
SECOND TREATMENT ARM
In the second treatment arm, the average correct responses
were 2.75 in the VPA group and 3.33 in the placebo group
(Figure 2). Participants performed at chance level in both groups
[VPA: t(7) = 0.333, ns., placebo: t(9) = 0.709, ns.]. In a One-
Way ANOVA with Condition (VPA/placebo) as a between-
subject factor, no difference was found between the two groups
[F(1, 16) = 0.452 ns.].
CROSSOVER
To compare the two treatment arms for the 18 participants who
completed the whole study (9 received VPA first, 8 placebo first
and as mentioned before, 1 participant’s data was corrupted
by a computer error), we also ran an ANOVA with Condition
(VPA/placebo) as a within-subject and Order (VPA first/placebo
first) as a between-subject factor (Figure 4). There was a main
effect of Order [F(1, 15) = 6.06, p = 0.03] due to significantly
higher AP scores overall for those who took VPA first. There was
also a significant interaction between the factors Condition and
Order [F(1, 15) = 8.85, p = 0.009]. To investigate this interaction,
we ran two post hoc ANOVAs, one for each treatment order, with
Condition (VPA/placebo) as a within-subject factor. For partic-
ipants who received VPA first, there was a significant effect of
Treatment [F(1, 8) = 20.25, p = 0.002] due to higher scores in
the VPA treatment condition compared to placebo. There was no
difference between VPA and placebo for the 8 participants who
received placebo first [F(1, 7) = 1.13, p = 0.32].
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Table 2 | Analysis of mood and cognitive measures in the first treatment arm.
Measure VPA Placebo Main effects Inter-actions
Pre Post Pre Post
MEASURES OF MOOD
VAS withdrawn/sociable 6.01 6.00 7.13 5.25 Time: pre > post
F(1, 22) = 4.36, p = 0.049
VAS depression 0.58 1.45 1.33 2.36 Time: pre < post
F(1, 22) = 7.71, p = 0.01
VAS irritable/peaceful 6.76 5.31 5.53 5.39 Time: pre > post
F(1, 22) = 4.63, p = 0.04
MEASURES OF COGNITION
VAS mentally slow/Quick-witted 6.82 6.03 4.78 4.99 Treatment: VPA > plac
F(1, 22) = 4.38, p = 0.048
RAVLT items 1–5 55.16 53.5 59.42 71.41 Time: pre < post
F(1, 22) = 4.82, p = 0.04
Treatment: VPA < plac
F(1, 22) = 4.38, p = 0.048
FIGURE 4 | Comparing the effects of VPA and placebo for each
treatment order. The red line indicates chance performance.
The ANOVAs over the mood and cognitive measures for the
crossover treatment yielded a significant Time X Treatment inter-
action [F(1, 16) = 4.54, p = 0.049] for the Altman Self-Rating
Mania Scale. Both treatment conditions were associated with
a trend toward lower scores post-treatment compared to pre-
treatment. However, the decrease from pre- to post-treatment
was greater in the VPA condition. A post hoc analysis revealed
that the change from before to after treatment was significant
for VPA (p = 0.03, with a Bonferroni correction for multiple
comparisons), but not for placebo (p = 0.76). We obtained no
significant Time X Treatment interaction on any other mea-
sure of mood or cognition. Table 3 provides a summary of the
results. Except for the RANDOT Stereoacuity test, we conducted
an ANOVA with Time (pre-treatment / post-treatment) and
Treatment (VPA/placebo) as within-subject factors and Order
(VPA first/placebo first) as a between-subject factor. For the ordi-
nal data from the RANDOT Stereoacuity test, we ran a Friedman
Test.
The experiment was double-blind, as neither participants,
nor experimenters knew the randomization for treatment con-
ditions. However, we did ask participants to intuit in which arm
they received VPA treatment, and why they thought so. We also
instructed them to write down any side effects they experienced
during the experiment. Out of the 18 participants who com-
pleted the second treatment arm, 17 guessed correctly. A small
number of them said they felt they were functioning at a higher
cognitive level when taking what they thought was the VPA,
but most said that mild side effects like drowsiness and nau-
sea were the primary cues that they used to determine which
was the active treatment. It needs to be noted, however, that
participants’ opinion about the drug taken was unlikely to influ-
ence the results for at least two reasons. First, participants could
guess, but could not be sure about the substance taken. Second,
they were naïve with respect to the hypothesis tested and could
thus not voluntarily influence their behavior in the expected
direction.
DISCUSSION
Until now we had no mechanistic account of the neural pro-
cesses underlying the critical period of AP. More generally,
we have lacked human experimental models with which to
measure the potential for a compound to facilitate neuro-
plasticity in the adult human brain. This study provides the
“proof-of-concept” for the possibility to restore neuroplastic-
ity using a drug by offering evidence for a possible effect
of VPA on AP perception. In confirmation of our hypothe-
sis, AP performance varied according to treatment condition.
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Table 3 | Analysis of mood and cognitive measures for crossover treatments.
Measure VPA first Placebo first Main effects Interactions
VPA Placebo VPA Placebo
Pre Post Pre Post Pre Post Pre Post
MEASURES OF MOOD
ASRM 5.80 3.00 4.10 4.10 4.13 2.38 3.25 2.75 Time X treatment
F(1, 16) = 4.54, p = 0.049
BDI II 7.10 7.00 5.10 4.90 6.00 4.00 8.38 8.00 Treatment X Order
F(1, 16) = 11.37,
p = 0.004
VAS irritable/peaceful 7.86 7.48 7.51 7.29 7.14 7.51 6.84 5.78 Treatment: VPA >
placebo
F(1, 16) = 4.89,
p = 0.04
VAS interested/
disinterested
2.20 2.81 1.70 1.84 3.98 3.18 3.85 3.46 Order : VPA first <
placebo first
F(1, 16) = 4.72,
p = 0.045
VAS sad 2.18 3.36 1.51 2.42 2.18 2.19 3.43 2.72 Treatment X order
F(1, 16) = 8.35, p = 0.01
VAS anxious 1.55 2.01 2.40 2.08 2.64 2.41 3.66 3.81 Treatment: VPA <
placebo
F(1, 16) = 4.56,
p = 0.049
VAS angry 0.72 1.88 1.90 1.77 1.56 1.10 2.51 1.36 Treatment: VPA <
placebo
F(1, 16) = 7.87, p =
0.01
Time X Order
F(1, 16) = 5.25, p = 0.04
VAS happy 6.64 5.85 7.69 6.65 6.61 7.35 6.36 6.71 Treatment X Order
F(1, 16) = 4.50, p = 0.0498
Time X Order
F(1, 16) = 4.75, p = 0.045
MEASURES OF COGNITION
RNBI composite
score
22.80 34.60 34.30 27.70 35.62 30.00 22.38 36.50 Time: pre > post
F(1, 16) = 6.76,
p = 0.02
Treatment X Order
F(1, 16) = 22.75, p < 0.001
RAVLT items 1–5 51.50 57.80 50.40 57.40 60.38 61.63 58.75 66.38 Time: pre < post
F(1, 16) = 32.43,
p < 0.001
VAS mentally slow/
quick-witted
7.31 5.99 7.23 6.68 4.91 6.20 4.84 6.03 Time X Order
F(1, 16) = 6.00, p = 0.03
VAS alert/drowsy 4.07 3.33 2.33 2.99 5.38 4.72 5.41 4.86 Order : VPA first <
placebo first
F(1, 16) = 5.02,
p = 0.04
Stroop color-word 43.80 46.40 50.60 53.40 54.62 54.50 48.25 52.38 Treatment X Order
F(1, 16) = 27.59, p < 0.001
Regan visual acuity
(Left Eye)
1.10 2.70 2.70 2.10 1.75 2.25 2.38 1.25 Treatment X Order
F(1, 16) = 8.10, p = 0.01
The only significant Time x Treatment interaction, indicating a differential effect of VPA on measures of mood and cognition pre- and post-treatment, is highlighted
in bold.
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Normal male volunteers performed significantly better on a test
of AP after 2 weeks of VPA treatment than after 2 weeks of
placebo.
Certain aspects of our findings warrant further discussion.
First, it was not possible to establish baseline performance on
the AP task, as the association between the musical notes and
the names was necessarily established during training. One possi-
ble option would have been to test participants’ AP performance
early in the regimen, while they were gradually reaching the full
dose of VPA. We had decided not to implement such a base-
line test, as no precise information was available regarding the
time course of the effect of VPA under the current conditions,
so AP training was only started on day 8, once participants have
reached the full dose. The absence of a baseline test might intro-
duce ambiguity into the interpretation of the effect. Indeed, there
are identifiable individual differences in musical ability, and in
the neuroanatomical structures supporting it (see Herholz and
Zatorre, 2012 for a review), which might have led to participants
with better AP abilities assigned to the VPA group in the first
treatment arm by chance. However, there is evidence in our study
that the significant effect of treatment for the AP task cannot be
fully accounted for by a between-group difference in the ability
to acquire AP. If such a difference were the driving force, then we
would have expected that in the second treatment arm the partic-
ipants in the potentially high-ability group (i.e., those who were
in the VPA condition for the first treatment arm) would outper-
form the low-ability group (i.e., those who were in the placebo
condition for the first treatment arm). However, this was not the
case. Further, since our participants were musically naïve (partic-
ipants who received musical training all started after the age of
7 years, with a mean of 12 years), the presence of complete or
partial AP possessors in either of the groups is very unlikely. As
reported above, there was no significant difference between the
two groups in the second treatment arm. Further, all of the top
scorers from the VPA condition in the first treatment arm com-
pleted the second treatment arm, eliminating the possibility that
the participants who completed the second treatment arm were
not representative of the group from the first treatment arm. This
strengthens our interpretation that the VPA treatment led to the
significantly higher performance in the VPA condition compared
to placebo.
Second, the analysis of the crossover, i.e., of the 17 partic-
ipants for whom we have data from both arms, revealed an
order-dependent effect of treatment. For participants who took
VPA first, AP performance was significantly higher after VPA
treatment than after placebo. In contrast, for participants who
initially took placebo, there was no such difference. It may be
that carry-over effects impeded performance on the AP task
in the second treatment arm. A memory conflict between the
pitch classes and proper names used in the first treatment arm
could have interfered with those used in the second. Because
of this order effect, the most reliable comparison focused on
the first treatment arm. Future research should aim to use a
randomized controlled trial (RCT) design with treatment con-
dition as a between-participants factor. Doing so would avoid
any possible carry-over effects from one treatment arm to the
next. Relatedly, it needs to be noted that we did not test how
long the effect of the improvement in AP perception lasted.
Future research will need to address this question by retesting
participants after several days or weeks following the end of
training.
Third, our study was not set up to measure reaction times.
Participants were informed that they had 4 s available for their
response with no instruction to do so rapidly. However, as
AP possessors are known to recognize pitch classes faster than
non-AP possessors do (Levitin and Rogers, 2005), reaction times
constitute a relevant measure to use in future follow-up studies.
Fourth, the sizes of the groups tested were relatively small
compared to some recent AP studies, which might explain why
no significant correlation was observed between AP performance
and training compliance, i.e., the amount of training received.
However, when compared to studies using VPA with healthy par-
ticipants, our sample sizes were quite appropriate (e.g., n = 12 in
the placebo as well as in the VPA group in the (Bell et al., 2005a,b)
study).
Fifth, we observed an effect of VPA on the Altman Self-Rating
Mania Scale. Indeed, VPA is commonly used as a mood stabi-
lizer to control mania in bipolar disorder (Macritchie et al., 2001).
Our results in healthy participants therefore confirmed the clini-
cal action of VPA, which may have an effect on sub-clinical levels
of mania as well. Importantly, however, an improved or more
stable mood in the VPA condition cannot explain the obtained
results, as we would then expect general cognitive improvement
in the other neurocognitive tasks administered, as well as greater
AP performance in both treatment arms.
In sum, our study is the first to show a change in AP with any
kind of drug treatment. The finding that VPA can restore plas-
ticity in a fundamental perceptual system in adulthood provides
compelling evidence that one of the modes of action for VPA
in psychiatric treatment may be to facilitate reorganization and
rewiring of otherwise firmly established pathways in the brain and
its epigenome (Shen et al., 2008).
Valproic acid is believed to have multiple pharmacological
actions, including acute blockade of GABA transaminase to
enhance inhibitory function in epileptic seizures and endur-
ing effects on gene transcription as an histone deacetlyase
(HDAC) inhibitor (Monti et al., 2009). Of relevance here is
the epigenetic actions of this drug, as enhancing inhibition
does not reactivate brain plasticity in adulthood (Fagiolini
and Hensch, 2000), but reopening chromatin structure does
(Putignano et al., 2007). While systemic drug application is
a rather coarse treatment, the effects may differ dramatically
by individual cell type (TK Hensch and P Carninci, unpub-
lished observations). VPA treatment mimics Nogo receptor dele-
tion to reopen plasticity for acoustic preference in mice (Yang
et al., 2012), suggesting a common pathway through the reg-
ulation of myelin-related signaling which normally closes crit-
ical period plasticity (McGee et al., 2005). Future work will
address the cellular actions of VPA treatment in the pro-
cess of reactivating critical periods. Future MRI studies will
also be needed to establish whether HDAC inhibition by
VPA induces hyperconnectivity of myelinated, long-range con-
nections concurrent with renewed AP ability (Loui et al.,
2011).
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If confirmed by future replications, our study will provide a
behavioral paradigm for the assessment of the potential of psy-
chiatric drugs to induce plasticity. In particular, the AP task may
be useful as a behavioral correlate. If further studies continue to
reveal specificity of VPA to the AP task (or to tasks on which train-
ing or intervention is provided), critical information will have
been garnered concerning when systemic drug treatments may
safely be used to reopen neural plasticity in a specific, targeted
way.
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